GEN Exclusives

More »

GEN News Highlights

More »
Dec 5, 2006

Oxford Gene Technology Tapped to Provide Microarrays for HIV Vaccine Research

  • Oxford Gene Technology (OGT) will design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology (CHAVI) project.

    OGT will design and develop an optimized oligonucleotide microarray to study genes of interest involved in the cellular immune response in early-stage HIV infected patients. The microarrays will be printed using the OGT ink jet in-situ synthesis platform. It will also investigate the use of its Multi Sample Array format enabling the parallel analysis of multiple samples. This will effectively reduce the cost per sample and speed up sample processing time.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?